542
Views
28
CrossRef citations to date
0
Altmetric
Original Article

Fifteen years’ experience of intestinal and multivisceral transplantation in the Nordic countries

, , , , , , , , , , , , , , , & show all
Pages 278-290 | Received 23 Oct 2014, Accepted 07 Dec 2014, Published online: 16 Jan 2015

References

  • Abu-Elmagd KM, Costa G, Bond GJ, Soltys K, Sindhi R, Wu T, et al. Five hundred intestinal and multivisceral transplantations at a single center: major advances with new challenges. Ann Surg 2009;250:567–81.
  • Mangus RS, Tector AJ, Kubal CA, Fridell JA, Vianna RM. Multivisceral transplantation: expanding indications and improving outcomes. J Gastrointest Surg 2013;17:179–86; discussion p 86-7.
  • Mazariegos GV, Steffick DE, Horslen S, Farmer D, Fryer J, Grant D, et al. Intestine Transplantation in the United States, 1999-2008 Am J Transplant 2010;10:1020–34.
  • Intestine Registry Report. 2011. Available from www.Intestinetransplant.org.
  • Kurvinen A, Nissinen MJ, Andersson S, Korhonen P, Ruuska T, Taimisto M, et al. Parenteral plant sterols and intestinal failure-associated liver disease in neonates. J Pediatr Gastroenterol Nutr 2012;54:803–11.
  • Ugur A, Marashdeh BH, Gottschalck I, Brobech Mortensen P, Staun M, Bekker Jeppesen P. Home parenteral nutrition in Denmark in the period from 1996 to 2001. Scand J Gastroenterol 2006;41(4):401–7.
  • Duraj F, Lindberg G, Groth CG, Eleborg L, Wernersson A, Saraste L, et al. [Intestinal transplantation. The first Swedish transplantation of the small intestine in an adult patient with pseudoobstruction]. Lakartidningen 1998;95:3172–6.
  • Buchman AL, Scolapio J, Fryer J. American Gastroenterological Association medical position statement: Short bowel syndrome and intestinal transplantation. Gastroenterology 2003;124:1105–10.
  • Vianna RM, Mangus RS. Present prospects and future perspectives of intestinal and multivisceral transplantation. Curr Opin Clin Nutr Metab Care 2009;12:281–6.
  • Kaufman SS, Atkinson JB, Bianchi A, Goulet OJ, Grant D, Langnas AN, et al. Indications for pediatric intestinal transplantation: a position paper of the American Society of Transplantation. Pediatr Transplant 2001;5:80–7.
  • Olausson M, Friman S, Herlenius G, Cahlin C, Nilsson O, Jansson S, et al. Orthotopic liver or multivisceral transplantation as treatment of metastatic neuroendocrine tumors. Liver Transpl 2007;13:327–33.
  • Herlenius G, Fagerlind M, Krantz M, Molne J, Olausson M, Gabel M, et al. Chronic kidney disease–a common and serious complication after intestinal transplantation. Transplantation 2008;86:108–13.
  • Reyes J, Mazariegos GV, Abu-Elmagd K, Macedo C, Bond GJ, Murase N, et al. Intestinal transplantation under tacrolimus monotherapy after perioperative lymphoid depletion with rabbit anti-thymocyte globulin (thymoglobulin). Am J Transplant 2005;5:1430–6.
  • Wu T, Abu-Elmagd K, Bond G, Nalesnik MA, Randhawa P, Demetris AJ. A schema for histologic grading of small intestine allograft acute rejection. Transplantation 2003;75:1241–8.
  • Ljungman P, Griffiths P, Paya C. Definitions of cytomegalovirus infection and disease in transplant recipients. Clin Infect Dis 2002;34:1094–7.
  • Green M, Michaels MG. Epstein-Barr virus infection and posttransplant lymphoproliferative disorder. Am J Transplant 2013;13:41–54. quiz.
  • Zhang Y, Ruiz P. Solid organ transplant-associated acute graft-versus-host disease. Arch Pathol Lab Med 2010;134:1220–4.
  • Tsutsumi Y, Tanaka J, Kato N, Zhang L, Mori A, Kobayasi R, et al. Analysis of mixed chimerism in patients after allogeneic stem cell transplantation using a capillary electrophoresis system. Acta Haematol 2002;107:195–202.
  • Audet M, Panaro F, Piardi T, Huang P, Cag M, Cinqualbre J, et al. Passenger lymphocyte syndrome and liver transplantation. Clin Dev Immunol 2008;2008:715769.
  • Smith EP. Hematologic disorders after solid organ transplantation. Hematology Am Soc Hematol Educ Program 2010;2010:281–6.
  • Lehtonen HJ, Sipponen T, Tojkander S, Karikoski R, Jarvinen H, Laing NG, et al. Segregation of a missense variant in enteric smooth muscle actin gamma-2 with autosomal dominant familial visceral myopathy. Gastroenterology 2012;143:1482–91; e3.
  • Sudan DL, Iyer KR, Deroover A, et al. A new technique for combined liver/small intestinal transplantation. Transplantation 2001;72:1846–8.
  • Beath S, Pironi L, Gabe S, Horslen S, Sudan D, Mazeriegos G, et al. Collaborative strategies to reduce mortality and morbidity in patients with chronic intestinal failure including those who are referred for small bowel transplantation. Transplantation 2008;85:1378–84.
  • Fishbein TM. Intestinal transplantation. N Engl J Med 2009;361:998–1008.
  • Pakarinen MP, Kurvinen A, Koivusalo AI, Ruuska T, Makisalo H, Jalanko H, et al. Surgical treatment and outcomes of severe pediatric intestinal motility disorders requiring parenteral nutrition. J Pediatr Surg 2013;48:333–8.
  • Oltean M, Aneman A, Dindelegan G, Molne J, Olausson M, Herlenius G. Monitoring of the intestinal mucosal perfusion using laser Doppler flowmetry after multivisceral transplantation. Transplant Proc 2005;37:3323–4.
  • Mercer DF. Hot topics in postsmall bowel transplantation: noninvasive graft monitoring including stool calprotectin and plasma citrulline. Curr Opin Organ Transplant 2011;16:316–22.
  • Quintini C, Kato T, Gaynor JJ, Ueno T, Selvaggi G, Gordon P, et al. Analysis of risk factors for the development of posttransplant lymphoproliferative disorder among 119 children who received primary intestinal transplants at a single center. Transplant Proc 2006;38:1755–8.
  • Mazariegos GV, Abu-Elmagd K, Jaffe R, Bond G, Sindhi R, Martin L, et al. Graft versus host disease in intestinal transplantation. Am J Transplant 2004;4:1459–65.
  • Sudan DL, Kaufman SS, Shaw BWJr, et al. Isolated intestinal transplantation for intestinal failure. Am J Gastroenterol 2000;95:1506–15.
  • Andres AM, Santamaria ML, Ramos E, Sarria J, Molina M, Hernandez F, et al. Graft-vs-host disease after small bowel transplantation in children. J Pediatr Surg 2010;45:330–6; discussion 6.
  • Wu G, Selvaggi G, Nishida S, Moon J, Island E, Ruiz P, et al. Graft-versus-host disease after intestinal and multivisceral transplantation. Transplantation 2011;91:219–24.
  • Kato T, Tzakis AG, Selvaggi G, Gaynor JJ, Takahashi H, Mathew J, et al. Transplantation of the spleen: effect of splenic allograft in human multivisceral transplantation. Ann Surg 2007;246:436–44. discussion 45; 6.
  • Cruz RJJr, Costa G, Bond G, Soltys K, Stein WC, Wu G, et al. Modified "liver-sparing" multivisceral transplant with preserved native spleen, pancreas, and duodenum: technique and long-term outcome. J Gastrointest Surg 2010;14:1709–21.
  • Edwards-Smith C, Goto S, Lord R, Shimizu Y, Vari F, Kamada N. Allograft acceptance and rejection, mediated by a liver suppressor factor, LSF-1, purified from serum of liver transplanted rats. Transpl Immunol 1996;4:287–92.
  • Calne R, Davies H. Organ graft tolerance: the liver effect. Lancet 1994;343:67–8.
  • Varkey J, Simren M, Bosaeus I, Krantz M, Gabel M, Herlenius G. Survival of patients evaluated for intestinal and multivisceral transplantation - the Scandinavian experience. Scand J Gastroenterol 2013;48:702–11.
  • Pavel M, Baudin E, Couvelard A, Krenning E, Oberg K, Steinmuller T, et al. ENETS Consensus Guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary. Neuroendocrinology 2012;95:157–76.
  • Fan ST, Le Treut YP, Mazzaferro V, Burroughs AK, Olausson M, Breitenstein S, et al. Liver transplantation for neuroendocrine tumour liver metastases. HPB (Oxford) 2014;17:23–8.
  • Frilling A, Modlin IM, Kidd M, Russell C, Breitenstein S, Salem R, et al. Recommendations for management of patients with neuroendocrine liver metastases. Lancet Oncol 2014;15:e8–21.
  • Vianna RM, Mangus RS, Kubal C, Fridell JA, Beduschi T, Tector AJ. Multivisceral transplantation for diffuse portomesenteric thrombosis. Ann Surg 2012;255:1144–50.
  • Sudan D, DiBaise J, Torres C, Thompson J, Raynor S, Gilroy R, et al. A multidisciplinary approach to the treatment of intestinal failure. J Gastrointest Surg 2005;9:165–76; discussion 76-7.
  • Kelly DA. Preventing parenteral nutrition liver disease. Early Hum Dev 2010;86:683–7.
  • Nandivada P, Chang MI, Potemkin AK, Carlson SJ, Cowan E, O’Loughlin A A, et al. The natural history of cirrhosis from parenteral nutrition-associated liver disease after resolution of cholestasis with parenteral fish oil therapy. Ann Surg 2013; Epub ahead of print.
  • Lacaille F, Vass N, Sauvat F, Canioni D, Colomb V, Talbotec C, et al. Long-term outcome, growth and digestive function in children 2 to 18 years after intestinal transplantation. Gut 2008;57:455–61.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.